- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Deliberate Learning Can Help Providers Adapt, Says Dr Lee Norman
Keeping up-to-date on information, whether it is about clinical matters or information systems, is critical to a deliberate learning mindset that is beneficial to health care providers, says Lee A. Norman, MD, MHS, MBA, the senior medical director for Optum Care Kansas City.
A deliberate learning mindset is beneficial for health care providers to have, said Lee A. Norman, MD, MHS, MBA, the senior medical director for Optum Care Kansas City. He served as the secretary of the Kansas Department of Health and Environment from 2019 to 2021 under Governor Laura Kelly. Norman, who also served in the US Air Force and later as a colonel in the Kansas Army National Guard, spoke in March at The American Journal of Managed Care®’s Institute for Value-Based Medicine® event on population health in Kansas City, Missouri.
Transcript
How can deliberate learning help health care providers be more open-minded and willing to adapt to change?
Yeah, deliberate learning—and I chose that word, well, very deliberately. And that was because a lot of times, physicians and just people in general want to close off their ears and say, there's just too much information, I just want to hunker down, do what I do, know what I know, and protect me from the rest of the world out there. Especially if people are in somewhat of a burnout situation, or they're just tired, they don’t want to learn anything new. But that's not going to carry the day, in a value-based world or a fee-for-service world.
Physicians and caregivers have to keep an open mind. I myself read probably an hour and a half a day—health systems information, clinical information, research studies, and the like—to always stay on top of things. And that is a very deliberate act. You have to stay up on things. That's deliberate learning.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
The study found significant disparities in the exposure to contaminants. Communities with higher percentages of Hispanic and Black residents were not only more likely to have unregulated chemicals in their drinking water, but they were also more frequently located near pollution sources.
Read More
Study Suggests Postdischarge Care Needs Targeted, Multifaceted Approaches
January 15th 2025The findings challenge the effectiveness of these widely used transitional care interventions and suggest a need for more targeted, multifaceted approaches to address the needs of higher-risk patients.
Read More
